127 related articles for article (PubMed ID: 6036078)
21. Effects of opiates and opiate antagonists on the Straub tail reaction in mice.
Aceto MD; McKean DB; Pearl J
Br J Pharmacol; 1969 Jun; 36(2):225-39. PubMed ID: 4389201
[TBL] [Abstract][Full Text] [Related]
22. Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.
Gyand EA; Kosterlitz HW
Br J Pharmacol Chemother; 1966 Sep; 27(3):514-27. PubMed ID: 5970903
[No Abstract] [Full Text] [Related]
23. Effects of morphine, levorphanol, nalorphine and naloxone on the release of acetylcholine from slices of rat cerebral cortex and hippocampus.
Large WA; Milton AS
Br J Pharmacol; 1971 Feb; 41(2):398P-399P. PubMed ID: 5572297
[No Abstract] [Full Text] [Related]
24. Brain acetylcholine levels and inhibition of the tail-flick reflex in mice.
Howes JF; Harris LS; Dewey WL; Voyda CA
J Pharmacol Exp Ther; 1969 Sep; 169(1):23-8. PubMed ID: 5804609
[No Abstract] [Full Text] [Related]
25. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone.
Blumberg H; Dayton HB; Wolf PS
Proc Soc Exp Biol Med; 1966 Dec; 123(3):755-8. PubMed ID: 4381176
[No Abstract] [Full Text] [Related]
26. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone.
Colasanti B; Khazan N
Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371
[No Abstract] [Full Text] [Related]
27. A simple quantitative method for the evaluation of physical dependence liability of morphine in mice.
Kaneto H; Nakanishi H
Jpn J Pharmacol; 1971 Jun; 21(3):411-3. PubMed ID: 5314728
[No Abstract] [Full Text] [Related]
28. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
Kosterlitz HW; Watt AJ
Br J Pharmacol Chemother; 1968 Jun; 33(2):266-76. PubMed ID: 5664147
[No Abstract] [Full Text] [Related]
29. Circulatory effects of cyclazocine. A non-narcotic analgesic.
Witherspoon CD; Montaner CG; Rusy BF
Anesth Analg; 1966; 45(2):176-8. PubMed ID: 5949074
[No Abstract] [Full Text] [Related]
30. A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs.
Ireson JD
Br J Pharmacol; 1970 Sep; 40(1):92-101. PubMed ID: 5487027
[TBL] [Abstract][Full Text] [Related]
31. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
Gilbert PE; Martin WR
J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
[TBL] [Abstract][Full Text] [Related]
32. The pharmacology of thebaine in the chronic spinal dog.
Gilbert PE; Martin WR
Drug Alcohol Depend; 1978 Mar; 3(2):139-42. PubMed ID: 564769
[TBL] [Abstract][Full Text] [Related]
33. Narcotic-antagonist analgesics: interactions with cholinergic systems.
Harris LS; Dewey WL; Howes JF; Kennedy JS; Pars H
J Pharmacol Exp Ther; 1969 Sep; 169(1):17-22. PubMed ID: 4389919
[No Abstract] [Full Text] [Related]
34. [Comparative studies of different narcotic antagonists].
Foldes FF
Arch Toxikol; 1968; 24(1):51-5. PubMed ID: 4884137
[No Abstract] [Full Text] [Related]
35. Naloxone reversal of pentazocine-induced respiratory depression.
Kallos T; Smith TG
JAMA; 1968 Jun; 204(10):932. PubMed ID: 5694610
[No Abstract] [Full Text] [Related]
36. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
Xie GX; Han JS
Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
[No Abstract] [Full Text] [Related]
37. The metabolic fate of H3-cyclazocine in dogs.
Mulé SJ; Clements TH; Gorodetzky CW
J Pharmacol Exp Ther; 1968 Apr; 160(2):387-96. PubMed ID: 5239862
[No Abstract] [Full Text] [Related]
38. Non-specificity of the mouse writhing test.
Chernov HI; Wilson DE; Fowler WF; Plummer AJ
Arch Int Pharmacodyn Ther; 1967 May; 167(1):171-8. PubMed ID: 6035094
[No Abstract] [Full Text] [Related]
39. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE
J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320
[No Abstract] [Full Text] [Related]
40. Discriminative effects of cyclazocine in the squirrel monkey.
Schaefer GJ; Holtzman SG
J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
